Text Size

Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by St George's Healthcare NHS Trust.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
St George's Healthcare NHS Trust
ClinicalTrials.gov Identifier:
NCT01154998
First received: June 30, 2010
Last updated: NA
Last verified: June 2010
History: No changes posted
  Purpose

There is a rare condition causing scarring of the lungs termed interstitial lung disease. This comprises a group of conditions which can be divided into separate diseases. The aim of this study is compare a group of patients (the cases) with 2 types of this disease (fibrotic non-specific interstitial pneumonia (NSIP) and idiopathic pulmonary fibrosis (IPF)) with patients without the disease. The study will look at the 2 groups and their exposures to factors such as medications, smoking, previous jobs, previous medical problems and specifically heart disease and any operations or procedures involving the heart. There have been previous studies showing a link between heart disease and scarring of the lungs. This study will look at whether this association is stronger in one or the other type of lung scarring diseases.


Condition
Idiopathic Pulmonary Fibrosis
Interstitial Pneumonia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Case-Control Study of Fibrotic Interstitial Lung Disease and it's Association With Cardiac Disease or Cardiac Intervention.

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by St George's Healthcare NHS Trust:

Estimated Enrollment: 360
Study Start Date: July 2010
Estimated Study Completion Date: April 2011
Estimated Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Cases
Controls

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Cases - patients with IPF or UIP. Controls - hospital clinic attenders.

Criteria

Inclusion Criteria:

  • idiopathic fibrotic lung disease

Exclusion Criteria:

  • non idiopathic fibrotic lung disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01154998

Contacts
Contact: Felix Chua, MBBS 0208 725 1261 felix.chua@stgeorges.nhs.uk

Locations
United Kingdom
St George's Hospital Not yet recruiting
London, United Kingdom, SW17 0QT
Sponsors and Collaborators
St George's Healthcare NHS Trust
  More Information

No publications provided

Responsible Party: Dr Felix Chua, St George's Healthcare NHS Trust
ClinicalTrials.gov Identifier: NCT01154998     History of Changes
Other Study ID Numbers: 10/H1102/46
Study First Received: June 30, 2010
Last Updated: June 30, 2010
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by St George's Healthcare NHS Trust:
non-specific interstitial pneumonia

Additional relevant MeSH terms:
Fibrosis
Heart Diseases
Lung Diseases
Pneumonia
Pulmonary Fibrosis
Lung Diseases, Interstitial
 Idiopathic Pulmonary Fibrosis
Pathologic Processes
Cardiovascular Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Idiopathic Interstitial Pneumonias

ClinicalTrials.gov processed this record on May 19, 2013